CN Patent

CN103393607A — 吡非尼酮与药物可接受的赋形剂的胶囊制剂

Assigned to Intermune Inc · Expires 2013-11-20 · 12y expired

What this patent protects

提供了一种包括药物可接受的赋形剂的吡非尼酮胶囊制剂。在一个实施方案中，该胶囊制剂能够在病人体内维持希望的药物代谢动力学响应。还提供了通过将这种制剂的吡非尼酮胶囊给药于有需要的病人而治疗纤维变性病症和其它细胞因子-介导的疾病的方法。

USPTO Abstract

提供了一种包括药物可接受的赋形剂的吡非尼酮胶囊制剂。在一个实施方案中，该胶囊制剂能够在病人体内维持希望的药物代谢动力学响应。还提供了通过将这种制剂的吡非尼酮胶囊给药于有需要的病人而治疗纤维变性病症和其它细胞因子-介导的疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN103393607A
Jurisdiction: CN
Classification: —
Expires: 2013-11-20
Drug substance claim: No
Drug product claim: No
Assignee: Intermune Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.